0000000000529841

AUTHOR

Marianna Di Piazza

showing 2 related works from this author

Surgical treatment of primary gastrointestinal stromal tumors (GISTs): Management and prognostic role of R1 resections

2020

Abstract Background Surgery represents the best treatment for primary gastrointestinal stromal tumors (GISTs). The aim of this study is to analyse outcomes of surgical management in order to evaluate the influence of microscopically R1 margins on survival and recurrence in patients affected by GISTs. Methods The study reviewed retrospective data from 74 patients surgically treated for primary GISTs without metastasis at diagnosis. Clinical and pathological findings, surgical procedures, information about follow up and outcomes were analyzed. Results Recurrence rate was low and no patients died in the R1 group during the follow up period. The difference in recurrence free survival for patien…

AdultMalemedicine.medical_specialtyGastrointestinal Stromal TumorsPrognosiMetastasisPositive microscopic margins03 medical and health sciences0302 clinical medicineHumansMedicineIn patientGastrointestinal stromal tumors (GISTs)Surgical treatmentPathologicalGISTsAgedRetrospective StudiesAged 80 and overGiSTbusiness.industryMargins of ExcisionGeneral MedicineMiddle AgedSurgical proceduresPrognosismedicine.diseaseSurgeryLog-rank test030220 oncology & carcinogenesisFemale030211 gastroenterology & hepatologySurgeryNeoplasm Recurrence LocalPositive microscopic marginbusinessGISTThe American Journal of Surgery
researchProduct

MUTYH-associated tumor syndrome: The other face of MAP

2022

MUTYH gene is involved in the base excision repair (BER) mechanism and its pathogenic alterations are associated with colorectal polyposis and cancer. MUTYH-associated polyposis (MAP) is a condition which is inherited in an autosomal recessive manner. MAP patients, beyond colorectal cancer (CRC), may develop other types of tumors, including duodenal, breast, ovarian, pancreatic, bladder and skin cancers. Carriers of biallelic MUTYH likely pathogenic/pathogenic variants exhibit a high lifetime risk of CRC, though cancer risk evidence becomes less clear when monoallelic carriers and extraintestinal tumors are considered. However, several studies recently reported an increased genetic suscepti…

Cancer ResearchAdenomatous Polyposis ColiSettore MED/06 - Oncologia MedicaMutationGeneticsHumansGenetic Predisposition to DiseaseColorectal NeoplasmsMolecular BiologyGerm-Line MutationDNA Glycosylases
researchProduct